BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 17172138)

  • 1. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls and progress in the diagnosis and management of canine inflammatory bowel disease.
    Simpson KW; Jergens AE
    Vet Clin North Am Small Anim Pract; 2011 Mar; 41(2):381-98. PubMed ID: 21486642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protein-losing enteropathy in Rottweilers].
    Dijkstra M; Kraus JS; Bosje JT; Den Hertog E
    Tijdschr Diergeneeskd; 2010 May; 135(10):406-12. PubMed ID: 20524405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A scoring index for disease activity in canine inflammatory bowel disease.
    Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
    J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical assessment of disease activity for canine inflammatory bowel disease.
    Jergens AE
    J Am Anim Hosp Assoc; 2004; 40(6):437-45. PubMed ID: 15533963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
    Jergens AE; Crandell J; Morrison JA; Deitz K; Pressel M; Ackermann M; Suchodolski JS; Steiner JM; Evans R
    J Vet Intern Med; 2010; 24(2):269-77. PubMed ID: 20051005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Jergens AE; Ackermann MR; Barr JW; Suchodolski JS; Steiner JM
    Am J Vet Res; 2012 Dec; 73(12):1900-7. PubMed ID: 23176415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic enteropathy.
    Allenspach K; Steiner JM; Shah BN; Berghoff N; Ruaux C; Williams DA; Blum JW; Gaschen F
    Am J Vet Res; 2006 Mar; 67(3):479-83. PubMed ID: 16506911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of disease activity markers in dogs with idiopathic inflammatory bowel disease.
    McCann TM; Ridyard AE; Else RW; Simpson JW
    J Small Anim Pract; 2007 Nov; 48(11):620-5. PubMed ID: 17608662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.
    Menozzi A; Dall'Aglio M; Quintavalla F; Dallavalle L; Meucci V; Bertini S
    BMC Vet Res; 2016 Oct; 12(1):217. PubMed ID: 27716258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
    Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
    BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic nitrite and immunoglobulin G concentrations in dogs with inflammatory bowel disease.
    Gunawardana SC; Jergens AE; Ahrens FA; Niyo Y
    J Am Vet Med Assoc; 1997 Aug; 211(3):318-21. PubMed ID: 9262670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose probiotics for the treatment of active pouchitis.
    Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
    Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease.
    Rossi G; Pengo G; Caldin M; Palumbo Piccionello A; Steiner JM; Cohen ND; Jergens AE; Suchodolski JS
    PLoS One; 2014; 9(4):e94699. PubMed ID: 24722235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
    Kathrani A; Schmitz S; Priestnall SL; Smith KC; Werling D; Garden OA; Allenspach K
    J Comp Pathol; 2011 Nov; 145(4):359-66. PubMed ID: 21592490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC; Heilmann RM; García-Sancho M; Sainz A; Ackermann MR; Suchodolski JS; Steiner JM; Jergens AE
    J Vet Intern Med; 2018 May; 32(3):999-1008. PubMed ID: 29624721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.